Segall Bryant & Hamill, LLC Corcept Therapeutics Inc Transaction History

Segall Bryant & Hamill, LLC

  • $7.1 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$62.24 - $91.93 $85,331 - $126,036
-1,371 Reduced 6.6%
19,393 $1.42 Million
Q1 2025

May 02, 2025
SELL
$49.85 - $114.22 $50,847 - $116,504
-1,020 Reduced 4.68%
20,764 $2.37 Million
Q4 2024

Feb 11, 2025
BUY
$44.66 - $60.85 $972,873 - $1.33 Million
21,784 New
21,784 $1.1 Million

Others Institutions Holding CORT

# of Institutions
478
Shares Held
80.5M
Call Options Held
596K
Put Options Held
710K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email